Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

Nianmin ShiBeijing Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaView further author information

Anvar RasuliGlobal Medical Affairs, Sanofi Pasteur, Lyon, FranceView further author information

Yaël ThollotGlobal Medical Affairs, Sanofi Pasteur, Lyon, FranceCorrespondence[email protected]
View further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Li Zhang. (2020) Hepatitis A vaccination. Human Vaccines & Immunotherapeutics 16:7, pages 1565-1573.
Read now

Articles from other publishers (1)

Sun Xiaojin, Lance E. Rodewald, Zhang Guomin, Zheng Hui, Miao Ning, Wang Fuzhen & Yin Zundong. (2020) Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China – A cross-sectional study. Vaccine 38:52, pages 8302-8309.
Crossref

Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

Citations (2)

Read on this site (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date